Header cover image

Japanese (NIKKEI) Drug Retail Industry Analysis

UpdatedJan 21, 2025
DataAggregated Company Financials
Companies20
  • 7D2.0%
  • 3M1.1%
  • 1Y-11.6%
  • YTDn/a

Over the last 7 days, the Drug Retail industry has risen 2.1%, driven by gains from COSMOS Pharmaceutical of 8.1%. In contrast, the industry has lost 11% in the last 12 months. Earnings are forecast to grow by 7.0% annually.

Industry Valuation and Performance

Has the Japanese Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 21 Jan 2025JP¥3.9tJP¥8.2tJP¥217.8b16.9x17.9x0.5x
Thu, 19 Dec 2024JP¥3.7tJP¥8.1tJP¥217.7b16.1x16.9x0.5x
Sat, 16 Nov 2024JP¥3.7tJP¥8.1tJP¥220.0b15.6x16.7x0.5x
Mon, 14 Oct 2024JP¥3.9tJP¥8.0tJP¥222.4b16.7x17.6x0.5x
Wed, 11 Sep 2024JP¥3.9tJP¥7.9tJP¥220.1b17.1x17.8x0.5x
Fri, 09 Aug 2024JP¥3.8tJP¥7.9tJP¥220.3b15.8x17.3x0.5x
Sun, 07 Jul 2024JP¥3.9tJP¥7.8tJP¥224.1b16.5x17.3x0.5x
Tue, 04 Jun 2024JP¥3.9tJP¥7.8tJP¥227.0b16.6x17.3x0.5x
Thu, 02 May 2024JP¥4.1tJP¥7.7tJP¥225.3b16.8x18.4x0.5x
Sat, 30 Mar 2024JP¥4.3tJP¥7.7tJP¥223.7b16.4x19.4x0.6x
Mon, 26 Feb 2024JP¥4.4tJP¥7.6tJP¥222.7b15.2x19.6x0.6x
Wed, 24 Jan 2024JP¥4.5tJP¥7.6tJP¥219.4b14.6x20.4x0.6x
Fri, 22 Dec 2023JP¥4.2tJP¥7.5tJP¥216.6b14.8x19.5x0.6x
Sun, 19 Nov 2023JP¥4.4tJP¥7.5tJP¥215.5b15.7x20.3x0.6x
Tue, 17 Oct 2023JP¥4.0tJP¥7.4tJP¥211.7b15.4x19.1x0.5x
Thu, 14 Sep 2023JP¥4.5tJP¥7.3tJP¥209.7b17.9x21.4x0.6x
Sat, 12 Aug 2023JP¥4.8tJP¥7.6tJP¥217.0b18.9x22.3x0.6x
Mon, 10 Jul 2023JP¥4.6tJP¥7.7tJP¥222.4b17.4x20.9x0.6x
Wed, 07 Jun 2023JP¥4.5tJP¥7.7tJP¥221.6b16.7x20.4x0.6x
Fri, 05 May 2023JP¥4.3tJP¥7.6tJP¥216.9b15.9x19.8x0.6x
Sun, 02 Apr 2023JP¥4.1tJP¥7.5tJP¥218.4b16.5x19x0.5x
Tue, 28 Feb 2023JP¥4.1tJP¥7.5tJP¥218.1b16.6x19x0.6x
Thu, 26 Jan 2023JP¥4.2tJP¥7.5tJP¥218.5b17.3x19.2x0.6x
Sat, 24 Dec 2022JP¥4.4tJP¥7.4tJP¥217.4b17.5x20.2x0.6x
Mon, 21 Nov 2022JP¥4.3tJP¥7.4tJP¥215.4b16.8x19.8x0.6x
Wed, 19 Oct 2022JP¥4.2tJP¥7.2tJP¥209.8b17x20.2x0.6x
Fri, 16 Sep 2022JP¥4.0tJP¥7.2tJP¥207.8b15.4x19.5x0.6x
Sun, 14 Aug 2022JP¥4.0tJP¥7.1tJP¥205.2b15.1x19.4x0.6x
Tue, 12 Jul 2022JP¥3.9tJP¥7.0tJP¥203.9b15x19.3x0.6x
Thu, 09 Jun 2022JP¥3.6tJP¥7.0tJP¥204.7b13.8x17.5x0.5x
Sat, 07 May 2022JP¥3.5tJP¥6.9tJP¥204.5b13.3x17x0.5x
Mon, 04 Apr 2022JP¥3.8tJP¥6.9tJP¥205.6b15.4x18.7x0.6x
Wed, 02 Mar 2022JP¥4.1tJP¥6.9tJP¥205.0b16.1x19.8x0.6x
Fri, 28 Jan 2022JP¥3.8tJP¥6.8tJP¥197.2b13.8x19.2x0.6x
Price to Earnings Ratio

19.2x


Total Market Cap: JP¥3.8tTotal Earnings: JP¥197.2bTotal Revenue: JP¥6.8tTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Drug Retail Industry Price to Earnings3Y Average 19x202320242025
Current Industry PE
  • Investors are relatively neutral on the Japanese Drug Retail industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 19.0x.
  • The industry is trading close to its 3-year average PS ratio of 0.55x.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have grown 3.4% per year over the last three years.
  • Revenues for these companies have grown 6.5% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Japanese Drug Retail compare with similar industries?

JP Market-0.21%
Consumer Staples-1.09%
Food and Staples Retail0.27%
Drug Retail2.00%
Big Box Super Stores1.30%
Food Distributors0.83%
Food Retail-0.81%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
3088 MatsukiyoCocokaraJP¥2.27k4.2%
+JP¥37.1b
-17.6%PE17.8x
3141 Welcia HoldingsJP¥2.28k5.9%
+JP¥26.2b
-4.4%PE22.6x
3391 Tsuruha HoldingsJP¥8.94k3.4%
+JP¥14.1b
-30.8%PE17.5x
7649 Sugi HoldingsLtdJP¥2.56k2.5%
+JP¥11.4b
12.6%PE18.7x
9989 SundrugLtdJP¥4.13k1.9%
+JP¥9.1b
-10.3%PE16.5x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

3148

JP¥2,780.00

Create SD Holdings

7D

1.5%

1Y

-12.0%

3353

JP¥2,150.00

Medical Ikkou GroupLtd

7D

-1.9%

1Y

-4.0%

7649

JP¥2,559.50

Sugi HoldingsLtd

7D

2.5%

1Y

12.6%

2796

JP¥513.00

Pharmarise Holdings

7D

-4.3%

1Y

-24.2%

9776

JP¥976.00

Sapporo Clinical Laboratory

7D

-0.9%

1Y

-4.2%

4558

JP¥209.00

ChukyoiyakuhinLtd

7D

-0.9%

1Y

0.5%